63 Dataanalyser gennem 96 ugers behandling i de tre POWER- forsøg påviste vedvarende antiretroviral effekt og immunologisk fordel.
Analyses of data through 96 weeks of treatment in the three POWER trials demonstrated sustained antiretroviral efficacy and immunological benefit.